Development of a highly sensitive radioimmunoassay for digoxin and its application in pediatric practice.
The sensitivity of two established routine digoxin radioimmunoassay methods has been increased to enable the provision of a rapid and relatively atraumatic inpatient and outpatient service for neonates and small children, using capillary blood samples obtained by heel-prick. The methods employ 125I- or 3H-labelled digoxin, a rabbit antiserum raised against a digoxin: bovine serum albumin conjugate and only 10 or 25 microliter of plasma as the sample. The results obtained using these highly sensitive assays correlate closely with those found using conventional assays, requiring larger sample volumes. An apparent difference in sensitivity to digoxin has been demonstrated between infants and children more than 1 yr old. Thus infants appear to tolerate plateau phase plasma levels (mean value for non toxic infants 2.6 +/- 1.8 ng/ml) that in older children or adults would be associated with digoxin toxicity.
D001666:Binding Sites, Antibody; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood* / Q000506:poisoning; D004361:Drug Tolerance; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011863:Radioimmunoassay / Q000379:methods*; D013997:Time Factors
D004077:Digoxin